Fk506 Inhibit Liver Regeneration in HOC Model Rat
Transplantation Proceedings · 2023
DOI: 10.1016/j.transproceed.2023.02.054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Binbin Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Ele…. Hauptthemen laut MEDLINE: Liver Regeneration, Focal Nodular Hyperplasia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Natural Science Foundation of Shanxi Province, Shanxi Provincial Department of Science and Technology.
Abstract (Originalsprache)
BACKGROUND: Studies have shown that lymphocytes support hepatic oval cell (HOC)-dependent liver regeneration and FK506(Tacrolimus) is known as an immunosuppressor. Therefore, we studied the role of FK506 in HOC activation and/or proliferation to guide the clinical use of FK506. METHODS: Thirty male Lewis rats were randomly divided into 4 groups: (A) intervene in activation (n = 8), (B) intervene in proliferation (n = 8), (C) control HOC model (n = 8), and (D) pure partial hepatectomy (PH) (n = 6). The HOC model was established by 2AAF(2-acetylaminofluorene)/PH in groups A to C. FK506 (at a dose of 1 mg/kg/d) was given subcutaneously in group A except on operation day, and not until day 8 post-operation (PO) in group B. Half of the animals were euthanized on days 10 and 14 PO, respectively. The remnant liver was weighed and stained by hematoxylin and eosin and immunohistochemical staining of proliferating cell nuclear antigen and epithelial cell adhesion molecule enabled HOC proliferation analysis. RESULTS: FK506 intervention exacerbated liver damage and hindered the recovery of the HOC model rat. Weight gain was severely retarded or even negative. Liver weight and the liver body weight ratio were lower than control group. HE and immunohistochemistry showed pooer proliferation of hepatocytes and fewer HOC numbers in group A. CONCLUSION: FK506 inhibited HOC activation by affecting T and NK cells, ultimately blocking liver regeneration. Poor liver regeneration after auxiliary liver transplantation might be associated with the inhibition of HOC activation and proliferation caused by FK506 treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Electronic address: zsbdzbb@163.com.
- Health Science Center of Xi'an Jiaotong University, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Förderung
- Natural Science Foundation of Shanxi Province
- Shanxi Provincial Department of Science and Technology
Zitieren
APA
Zhang, B., Han, B., Gao, F., Fu, X., & Tian, Y. (2023). Fk506 Inhibit Liver Regeneration in HOC Model Rat. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.02.054
Vancouver
Zhang B, Han B, Gao F, Fu X, Tian Y. Fk506 Inhibit Liver Regeneration in HOC Model Rat. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.02.054
BibTeX
@article{Zhang2023,
author = {Zhang, Binbin and Han, Bing and Gao, Fei and Fu, Xifeng and Tian, Yanzhang},
title = {Fk506 Inhibit Liver Regeneration in HOC Model Rat},
journal = {Transplantation Proceedings},
year = {2023},
doi = {10.1016/j.transproceed.2023.02.054}
}
EUVIMED